Timing the Brain's Repair: UCSF Maps Critical Windows After Newborn Birth Injury
When complications during birth cut off oxygen to a newborn's brain, the injury doesn't end when oxygen is restored. The brain mounts a repair response that walks a tightrope: too little, and damaged tissue remains vulnerable; too much, and permanent scars can block recovery.
Each year, approximately 10,000 infants in the United States experience this brain injury, known as hypoxic-ischemic encephalopathy. Survivors can face serious neurodevelopmental issues, including cerebral palsy. The current standard treatment — cooling the infant's body to slow the cascade of damage — has improved outcomes but doesn't fully prevent brain injury in many cases.
By mapping when and where the brain's repair response unfolds at the molecular level, researchers from the UCSF Department of Pediatrics have identified potential windows for a different kind of intervention — one that works with the brain's own biology rather than simply slowing it down. The paper was recently published in Cells.
Wave One: Cleanup. Wave Two: Containment.
When the brain is deprived of oxygen, cells die — and the debris they leave behind can trigger widespread inflammation that damages nearby healthy tissue. The brain's immune cells, called microglia, respond in two distinct waves.
Within the first 24 hours, microglia become cleanup crews. They clear away dead cells through a process called efferocytosis, calm inflammatory signals, and prepare the damaged area for repair.
By day five, the same microglia shift to create scar tissue. “A scar-forming phenotype emerges within the first day after injury and becomes dominant by day five,” says Jana Mike, MD, PhD, a pediatric critical care specialist at UCSF and co-senior author of the study. “While this protective response serves an important short-term role in sealing and stabilizing the injury, in the developing brain it can interfere with normal maturation.”
A Protein That Orchestrates Both Phases
The study used advanced molecular profiling to track gene activity in microglia within the hippocampus — a region critical for memory and learning that is especially vulnerable to oxygen deprivation in newborns. This approach captures not just which genes are active, but where in the brain and when after injury.
The team discovered that one protein, Arginase-1 (ARG1), plays a central role in both phases — but its job changes over time. In the first 24 hours, ARG1 appeared broadly across the brain, coordinating the cleanup response. By day five, it concentrated in the hippocampus, shifting the area toward scar formation.
“That dual role makes ARG1 a compelling but complicated therapeutic target,” says Eesha Natarajan, MBBS, corresponding author of the paper and fellow in the UCSF Division of Pediatric Critical Care. “Blocking it could limit permanent damage from scarring, but if that happens too early, the initial cleanup could be impaired.”
When Injury Response Meets Normal Growth
The research also revealed that the same molecular programs that drive the injury response are essential for normal brain development. Under healthy conditions, microglia use ARG1 and other involved pathways to shape neural circuits, prune unnecessary connections, and support the maturation of learning and memory systems.
After injury, these cells get redirected toward repair and scarring — meaning clinicians cannot simply shut them down without risking harm to the developmental processes a newborn brain still needs.
"By defining the timeline of the brain’s repair response, we can begin to design interventions that are precisely timed and calibrated, shaping the response rather than simply blocking it,” says Jana Mike.
A Roadmap for Time-Sensitive Treatment
By mapping the precise timeline of each phase, the research opens new routes for potential interventions. During the first 24 to 48 hours, therapies could enhance efficient debris clearance and limit collateral inflammation. During the later window, interventions could temper the processes that create dense, permanent scars — not to prevent all scarring, which is initially protective, but to prevent it from becoming excessive.
“Our goal is really to understand the different mechanisms at play so we can shift the balance away from injurious processes and toward reparative pathways,” adds Fernando Gonzalez, MD, co-senior author of the paper and chief of the UCSF Division of Neonatology. “If we can identify an intervention or a strategy after injury that significantly improves long-term outcomes, that would be the holy grail.”
Authors: Other authors from the UCSF Department of Pediatrics include: Michael Smith, MD; Carlos Lizama-Valenzuela, PhD; Thomas Arnold, MD; David Stroud; Amara Larpthaveesarp; Cristina Alvira, MD; Jeffrey Fineman, MD; Donna Ferriero, MD; and Emin Maltepe, MD, PhD.
Funding: This study was supported by the National Institutes of Health grants K08NS125042, R01 HD072455, and NIH-NEI P30 EY002162/EY037668.